#china-biotech
#china-biotech

[ follow ]

China's biotech boom: why the nation must collaborate to stay ahead

China leads in drug manufacturing and biotech innovation, but geopolitical scrutiny and moves toward a closed biotech ecosystem threaten scientific collaboration and global medicine access.

Intellectual property law

fromIPWatchdog.com | Patents & Intellectual Property Law

2 months ago

To Beat China at Drug Innovation, Big Pharma and Generics Need the Supreme Court to End This Patent Absurdity

The Federal Circuit's panel-dependent jurisprudence and the "after-arising technology" exception enable patent evergreening, undermining U.S. biopharma competitiveness versus China.

World news

fromAxios

5 months ago

China pharma deals threaten U.S. biotech

China is rapidly becoming a global leader in biotech, AI and chemistry, capturing rising licensing deals while U.S. research funding cuts risk ceding leadership.

[ Load more ]

#china-biotech#china-biotech

China's biotech boom: why the nation must collaborate to stay ahead

To Beat China at Drug Innovation, Big Pharma and Generics Need the Supreme Court to End This Patent Absurdity

China pharma deals threaten U.S. biotech

#china-biotech
#china-biotech